← Leaderboards
Michael A White
University Of Texas Sw Med Ctr/Dallas
$8,759,382
Attributed
$10,859,662
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$13,447,738 · 8
By mechanism
R01$6,083,430 · 2
U41$3,061,331 · 2
U01$2,800,374 · 1
R21$777,150 · 2
R35$725,453 · 1
Top collaborators
- John B Macmillan8 shared
- Roger G Linington4 shared
- John D Minna4 shared
- Michael G Roth4 shared
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- James V Jester$13,692,727
- Jef Karel De Brabander$8,898,818
- Joseph L Goldstein$29,369,162
- Peter John Espenshade$14,189,166
- John D Minna$17,722,080
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularPathway InteractionsCellsBaseCancer CellSignal TransductionCell ProliferationMediatingCell SurvivalRegulationMalignant NeoplasmsOncogenicResponseFamilyCell PhysiologyGuanosine Triphosphate PhosphohydrolasesProteinsProgramsGenerationsGrowthNeoplastic CellCyclinsGeneticCellular Structures
Grant awards (50)
MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White)$91,800
U41 · FY2019 · AT · contact PI
MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White)$152,970
U41 · FY2018 · AT · contact PI
MacMillan: Overall; The Center for High-Throughput Functional Annotation of Natural Products (McMillan)$329,519
U41 · FY2017 · AT
MacMillan: Overall; The Center for High-Throughput Functional Annotation of Natural Products (McMillan)$301,000
U41 · FY2017 · AT
MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White)$63,112
U41 · FY2017 · AT · contact PI
MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White)$39,344
U41 · FY2017 · AT · contact PI
MacMillan: Overall; The Center for High-Throughput Functional Annotation of Natural Products (McMillan)$964,292
U41 · FY2016 · AT
Lung cancer oncogenotype-selective drug target discovery$706,409
U01 · FY2016 · CA
MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White)$63,112
U41 · FY2016 · AT · contact PI
MacMillan: Overall; The Center for High-Throughput Functional Annotation of Natural Products (McMillan)$993,265
U41 · FY2015 · AT
Targeting Mechanistic Subtypes of Neoplastic Disease$725,453
R35 · FY2015 · CA · contact PI
Lung cancer oncogenotype-selective drug target discovery$706,409
U01 · FY2015 · CA
Components of Ras-mediated growth control$324,730
R01 · FY2015 · CA · contact PI
MacMillan: Project 3; Technology Development and Research Project #3: Bioinformatics (White)$62,917
U41 · FY2015 · AT · contact PI
Lung cancer oncogenotype-selective drug target discovery$685,218
U01 · FY2014 · CA
Components of Ras-mediated growth control$314,988
R01 · FY2014 · CA · contact PI
Lung cancer oncogenotype-selective drug target discovery$702,338
U01 · FY2013 · CA
Components of Ras-mediated growth control$305,246
R01 · FY2013 · CA · contact PI
Components of Ras-mediated growth control$324,390
R01 · FY2012 · CA · contact PI
Components of Ras-mediated growth control$323,709
R01 · FY2011 · CA · contact PI
The RaLGTPase Regulatory Network$231,481
R01 · FY2011 · CA · contact PI
Components of Ras-Mediated Growth Control$261,370
R01 · FY2010 · CA · contact PI
The RaLGTPase Regulatory Network$238,640
R01 · FY2010 · CA · contact PI
Molecular components specifying mucosal cell sensitivity to influenza infection$235,500
R21 · FY2010 · AI · contact PI
The RaLGTPase Regulatory Network$64,948
R01 · FY2010 · CA · contact PI
Components of Ras-Mediated Growth Control$64,189
R01 · FY2010 · CA · contact PI
Components of Ras-Mediated Growth Control$261,370
R01 · FY2009 · CA · contact PI
The RaLGTPase Regulatory Network$238,640
R01 · FY2009 · CA · contact PI
Molecular components specifying mucosal cell sensitivity to influenza infection$196,250
R21 · FY2009 · AI · contact PI
The RaLGTPase Regulatory Network$64,948
R01 · FY2009 · CA · contact PI
Components of Ras-Mediated Growth Control$62,503
R01 · FY2009 · CA · contact PI
Components of Ras-Mediated Growth Control$59,275
R01 · FY2009 · CA · contact PI
Components of Ras-Mediated Growth Control$261,370
R01 · FY2008 · CA · contact PI
The RaLGTPase Regulatory Network$238,640
R01 · FY2008 · CA · contact PI
Deriving Combinatorial Strategies for Therapy of Pancreatic Cancer$219,800
R21 · FY2008 · CA · contact PI
Components of Ras-Mediated Growth Control$60,866
R01 · FY2008 · CA · contact PI
Components of Ras-Mediated Growth Control$59,275
R01 · FY2008 · CA · contact PI
Components of Ras-Mediated Growth Control$261,370
R01 · FY2007 · CA · contact PI
The RaLGTPase Regulatory Network$238,640
R01 · FY2007 · CA · contact PI
Deriving Combinatorial Strategies for Therapy of Pancreatic Cancer$125,600
R21 · FY2007 · CA · contact PI
Components of Ras-Mediated Growth Control$59,275
R01 · FY2007 · CA · contact PI
Components of Ras-Mediated Growth Control$28,362
R01 · FY2007 · CA · contact PI
Components of Ras-Mediated Growth Control$269,177
R01 · FY2006 · CA · contact PI
Components of Ras-Mediated Growth Control$32,778
R01 · FY2006 · CA · contact PI
COMPONENTS OF RAS MEDIATED GROWTH CONTROL$68,250
R01 · FY2005 · CA
COMPONENTS OF RAS MEDIATED GROWTH CONTROL$273,000
R01 · FY2004 · CA
COMPONENTS OF RAS MEDIATED GROWTH CONTROL$273,000
R01 · FY2003 · CA
COMPONENTS OF RAS MEDIATED GROWTH CONTROL$273,000
R01 · FY2002 · CA
COMPONENTS OF RAS MEDIATED GROWTH CONTROL$273,000
R01 · FY2001 · CA
COMPONENTS OF RAS MEDIATED GROWTH CONTROL$273,000
R01 · FY2000 · CA